在肌痛性骨髓灰质炎的救援疗法
1Ellen and Martin Prosserman Centre for Neuromuscular Disease, University Health Network, Toronto, Ontario, Canada.
International review of neurobiology
|October 16, 2025
概括
骨髓灰质炎 (MG) 救援疗法,包括IVIG和PLEX,可以治疗急性恶化. 像eculizumab这样的新疗法为面临危机的肌痛大症患者提供了新的希望.
科学领域:
- 神经学 神经学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 骨髓灰质炎 (MG) 是一种慢性自身免疫神经肌肉疾病.
- 波动性肌肉衰弱是由于神经肌肉传输受损而导致的.
- 尽管目前的治疗方法,急性恶化和肌性危机带来了重大的临床挑战.
研究的目的:
- 为了提供一个全面的概述的救援疗法为严重肌痛性肌痛症.
- 详细介绍既有和新型急性MG治疗的机制,疗效和安全性.
- 引导临床医生优化救援疗法,以改善患者的治疗结果.
主要方法:
- 已建立的救援疗法的审查:静脉注射免疫球蛋白 (IVIG) 和血交换 (PLEX).
- 讨论新兴疗法:Eculizumab和Efgartigimod用于急性MG管理.
- 强调基于抗体状况,疾病严重程度和并发症的个性化治疗策略.
主要成果:
- 已建立的疗法 (IVIG,PLEX) 在MG恶化期间提供了至关重要的支持.
- 新型药物 (eculizumab,efgartigimod) 在治疗MG的急性阶段方面表现有前途.
- 个性化的方法和警的监控是成功管理的关键.
结论:
- 优化救援治疗对于改善肌痛性骨髓灰质炎急性恶化和危机的结果至关重要.
- 结合既定和新型疗法,根据个体患者的个人资料量身定制,至关重要.
- 为了推进MG危机护理,需要持续的研究和临床警.
更多相关视频
相关概念视频
Myasthenia Gravis: Overview and Treatment
2.8K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.8K
Myasthenia Gravis: Diagnostic Tests
1.9K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.9K
Skeletal Muscle Relaxants: Therapeutic Uses
886
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
886
Disorders of the Skeletal Muscle
1.7K
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
1.7K
Acute Respiratory Failure-V
451
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
451
Anticholinesterase Agents: Poisoning and Treatment
1.5K
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
1.5K


